Report cover image

Targeted Alpha Therapies for Cancer Treatment: Global Market

Publisher BCC Research
Published Sep 11, 2025
Length 81 Pages
SKU # WA20408095

Description

Report Scope

The report provides an overview of the global market for targeted alpha therapies (TAT) for cancer and analyzes market trends. It includes global revenue ($ million) for the base year data 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented based on cancer type.

The report focuses on trends and challenges that affect the market and vendor landscape. It analyzes corporate environmental, social and governance (ESG) developments and discusses emerging technologies related to the market. The report includes an analysis of the competitive landscape and pipeline analysis. A section dedicated to company profiles addresses key financials, product portfolios and recent developments involving industry leaders.

Report Includes
  • Overview and an analysis of the global market for targeted alpha therapies (TAT) for cancer treatment
  • Analyses of the global market trends, with historical market revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
  • Estimates of the current market size and revenue prospects of the global market, accompanied by a market share analysis by cancer type and region
  • Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
  • Insights derived from Porter’s Five Forces model, and information on emerging trends and technologies, latest developments, and product pipeline analysis
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
  • A relevant patent analysis, featuring key granted and published patents
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
  • Profiles of the leading companies


Companies Mentioned

Actinium Pharmaceuticals Inc.
Advancell Pty Ltd.
Bayer Ag
Convergent Therapeutics Inc.
Fusion Pharm
Novartis Ag
Orano Med
Perspective Therapeutics
Radiomedix Inc.
Rayzebio Inc.

Table of Contents

81 Pages
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of the U.S. Tariff Laws
Porter's Five Forces Analysis
Potential of New Entrants: Moderate to Low
Bargaining Power of Suppliers: High
Bargaining Power of Buyers: Moderate
Threat of Substitute Products or Services: Moderate
Industry Competition: Low
Value Chain Analysis
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increased Prevalence of Cancer
Demand for Precision Medicine
Unmet Treatment Need in Oncology
Increased Strategic Initiatives
Market Restraints
Supply Chain and Manufacturing Issues
Regulatory Hurdles
Market Challenges
Dosimetry Calculations
Recoil Effect
Market Opportunities
New Targets
Combination Therapies
Chapter 4 Regulatory Landscape
Regulatory Scenario
The U.S.
European Union
Japan
Chapter 5 Emerging Technologiesand Developments
Emerging Technologies
Advances in Drug Delivery Strategies
Theranostics
Pipeline Analysis
Key Takeaways
Chapter 6 Market Segmentation Analysis
Overview
Segmentation Breakdown
Market Analysis by Cancer Type
Key Takeaways
Prostate Cancer
Neuroendocrine Tumors
Other Cancers
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Market Analysis
Strategic Initiatives
Agreements, Collaborations and Partnerships
Acquisitions
Other Strategies
Chapter 8 Sustainability in Targeted Alpha Therapies for Cancer Treatment Market: An ESG Perspective
Introduction to ESG
Sustainability in the Targeted Alpha Therapies Industry
ESG Performance Analysis
Environmental Initiatives
Social Initiatives
Governance Initiatives
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
ACTINIUM PHARMACEUTICALS INC.
ADVANCELL PTY LTD.
BAYER AG
CONVERGENT THERAPEUTICS INC.
FUSION PHARM
NOVARTIS AG
ORANO MED
PERSPECTIVE THERAPEUTICS
RADIOMEDIX INC.
RAYZEBIO INC.
Emerging Startups in the Market

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us